Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 533

1.

Qualitative and quantitative comparison of PET/CT and PET/MR imaging in clinical practice.

Al-Nabhani KZ, Syed R, Michopoulou S, Alkalbani J, Afaq A, Panagiotidis E, O'Meara C, Groves A, Ell P, Bomanji J.

J Nucl Med. 2014 Jan;55(1):88-94. doi: 10.2967/jnumed.113.123547.

2.

Integrated whole-body PET/MR hybrid imaging: clinical experience.

Quick HH, von Gall C, Zeilinger M, Wiesmüller M, Braun H, Ziegler S, Kuwert T, Uder M, Dörfler A, Kalender WA, Lell M.

Invest Radiol. 2013 May;48(5):280-9. doi: 10.1097/RLI.0b013e3182845a08.

PMID:
23442775
3.

First clinical experience with integrated whole-body PET/MR: comparison to PET/CT in patients with oncologic diagnoses.

Drzezga A, Souvatzoglou M, Eiber M, Beer AJ, Fürst S, Martinez-Möller A, Nekolla SG, Ziegler S, Ganter C, Rummeny EJ, Schwaiger M.

J Nucl Med. 2012 Jun;53(6):845-55. doi: 10.2967/jnumed.111.098608.

4.

Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.

Eiber M, Takei T, Souvatzoglou M, Mayerhoefer ME, Fürst S, Gaertner FC, Loeffelbein DJ, Rummeny EJ, Ziegler SI, Schwaiger M, Beer AJ.

J Nucl Med. 2014 Feb;55(2):191-7. doi: 10.2967/jnumed.113.123646.

5.

Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues.

Pace L, Nicolai E, Luongo A, Aiello M, Catalano OA, Soricelli A, Salvatore M.

Eur J Radiol. 2014 Feb;83(2):289-96. doi: 10.1016/j.ejrad.2013.11.002.

PMID:
24331845
6.

Qualitative and quantitative performance of ¹⁸F-FDG-PET/MRI versus ¹⁸F-FDG-PET/CT in patients with head and neck cancer.

Partovi S, Kohan A, Vercher-Conejero JL, Rubbert C, Margevicius S, Schluchter MD, Gaeta C, Faulhaber P, Robbin MR.

AJNR Am J Neuroradiol. 2014 Oct;35(10):1970-5. doi: 10.3174/ajnr.A3993.

7.

PET/MRI with diagnostic MR sequences vs PET/CT in the detection of abdominal and pelvic cancer.

Xin J, Ma Q, Guo Q, Sun H, Zhang S, Liu C, Zhai W.

Eur J Radiol. 2016 Apr;85(4):751-9. doi: 10.1016/j.ejrad.2016.01.010.

PMID:
26971419
8.

Evaluation of ¹⁸F-FDG PET/MRI, ¹⁸F-FDG PET/CT, MRI, and CT in whole-body staging of recurrent breast cancer.

Sawicki LM, Grueneisen J, Schaarschmidt BM, Buchbender C, Nagarajah J, Umutlu L, Antoch G, Kinner S.

Eur J Radiol. 2016 Feb;85(2):459-65. doi: 10.1016/j.ejrad.2015.12.010.

PMID:
26781152
9.

Qualitative FDG PET Image Assessment Using Automated Three-Segment MR Attenuation Correction Versus CT Attenuation Correction in a Tertiary Pediatric Hospital: A Prospective Study.

Lyons K, Seghers V, Williams JL, Sorensen JI, Paldino MJ, Krishnamurthy R, Rohren EM.

AJR Am J Roentgenol. 2015 Sep;205(3):652-8. doi: 10.2214/AJR.14.14231.

PMID:
26295654
10.

Pulmonary lesion assessment: comparison of whole-body hybrid MR/PET and PET/CT imaging--pilot study.

Schwenzer NF, Schraml C, Müller M, Brendle C, Sauter A, Spengler W, Pfannenberg AC, Claussen CD, Schmidt H.

Radiology. 2012 Aug;264(2):551-8. doi: 10.1148/radiol.12111942.

PMID:
22653189
11.

Comparison of lesion detection and quantitation of tracer uptake between PET from a simultaneously acquiring whole-body PET/MR hybrid scanner and PET from PET/CT.

Wiesmüller M, Quick HH, Navalpakkam B, Lell MM, Uder M, Ritt P, Schmidt D, Beck M, Kuwert T, von Gall CC.

Eur J Nucl Med Mol Imaging. 2013 Jan;40(1):12-21. doi: 10.1007/s00259-012-2249-y.

PMID:
23053323
12.

Whole-body-MR imaging including DWIBS in the work-up of patients with head and neck squamous cell carcinoma: a feasibility study.

Noij DP, Boerhout EJ, Pieters-van den Bos IC, Comans EF, Oprea-Lager D, Reinhard R, Hoekstra OS, de Bree R, de Graaf P, Castelijns JA.

Eur J Radiol. 2014 Jul;83(7):1144-51. doi: 10.1016/j.ejrad.2014.03.019.

13.

Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.

Schmidt H, Brendle C, Schraml C, Martirosian P, Bezrukov I, Hetzel J, Müller M, Sauter A, Claussen CD, Pfannenberg C, Schwenzer NF.

Invest Radiol. 2013 May;48(5):247-55. doi: 10.1097/RLI.0b013e31828d56a1.

PMID:
23519008
14.

Impact of time-of-flight PET on quantification errors in MR imaging-based attenuation correction.

Mehranian A, Zaidi H.

J Nucl Med. 2015 Apr;56(4):635-41. doi: 10.2967/jnumed.114.148817.

15.

18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.

Giraudo C, Raderer M, Karanikas G, Weber M, Kiesewetter B, Dolak W, Simonitsch-Klupp I, Mayerhoefer ME.

Invest Radiol. 2016 Mar;51(3):163-9. doi: 10.1097/RLI.0000000000000218.

16.

Detection rate, location, and size of pulmonary nodules in trimodality PET/CT-MR: comparison of low-dose CT and Dixon-based MR imaging.

Stolzmann P, Veit-Haibach P, Chuck N, Rossi C, Frauenfelder T, Alkadhi H, von Schulthess G, Boss A.

Invest Radiol. 2013 May;48(5):241-6. doi: 10.1097/RLI.0b013e31826f2de9.

PMID:
23070096
17.

Non-small cell lung cancer: whole-body MR examination for M-stage assessment--utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT.

Ohno Y, Koyama H, Onishi Y, Takenaka D, Nogami M, Yoshikawa T, Matsumoto S, Kotani Y, Sugimura K.

Radiology. 2008 Aug;248(2):643-54. doi: 10.1148/radiol.2482072039.

PMID:
18539889
18.

Whole-body nonenhanced PET/MR versus PET/CT in the staging and restaging of cancers: preliminary observations.

Huellner MW, Appenzeller P, Kuhn FP, Husmann L, Pietsch CM, Burger IA, Porto M, Delso G, von Schulthess GK, Veit-Haibach P.

Radiology. 2014 Dec;273(3):859-69. doi: 10.1148/radiol.14140090.

PMID:
25102372
19.

PET/MR imaging in the detection and characterization of pulmonary lesions: technical and diagnostic evaluation in comparison to PET/CT.

Rauscher I, Eiber M, Fürst S, Souvatzoglou M, Nekolla SG, Ziegler SI, Rummeny EJ, Schwaiger M, Beer AJ.

J Nucl Med. 2014 May;55(5):724-9. doi: 10.2967/jnumed.113.129247.

20.

Staging of neuroendocrine tumours: comparison of [⁶⁸Ga]DOTATOC multiphase PET/CT and whole-body MRI.

Schraml C, Schwenzer NF, Sperling O, Aschoff P, Lichy MP, Müller M, Brendle C, Werner MK, Claussen CD, Pfannenberg C.

Cancer Imaging. 2013 Mar 5;13:63-72. doi: 10.1102/1470-7330.2013.0007.

Supplemental Content

Support Center